Evaluation of the AdvanSure One-Stop COVID-19 Plus Kit for SARS-CoV-2 Detection Using a Streamlined RNA Extraction Method
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Real-time reverse transcription (rRT)-PCR, which is the reference standard for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, generally involves a time-consuming and costly RNA extraction step prior to amplification. We evaluated the performance of the AdvanSure One-Stop COVID-19 Plus Kit (LG Chem, Seoul, Korea), a novel rRT-PCR assay that can detect SARS-CoV-2 within 90 minutes using a streamlined RNA extraction method. In total, 509 nasopharyngeal swab (NPS) specimens (SARS-CoV-2 positive: N=205; SARS-CoV-2 negative: N=304) previously tested using the PowerChek SARS-CoV-2 Real-time PCR Kit (Kogene Biotech, Seoul, Korea) were tested using the AdvanSure assay. The limit of detection (LOD) of the AdvanSure assay was determined using serially diluted inactivated SARS-CoV-2. The positive and negative percent agreements between the AdvanSure and PowerChek assays were 99.5% (204/205) and 99.3% (302/304), respectively. The LODs of the AdvanSure assay for SARS-CoV-2 nucleocapsid and spike/RNA-dependent RNA polymerase genes were 672 and 846 copies/mL, respectively. The results show that the performance of the AdvanSure assay is comparable to that of the PowerChek assay used for routine SARS-CoV-2 testing, suggesting that the AdvanSure assay is a useful diagnostic tool for rapid and accurate detection of SARS-CoV-2 infection.
Abstract
Real-time reverse transcription (rRT)-PCR, which is the reference standard for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, generally involves a time-consuming and costly RNA extraction step prior to amplification. We evaluated the performance of the AdvanSure One-Stop COVID-19 Plus Kit (LG Chem, Seoul, Korea), a novel rRT-PCR assay that can detect SARS-CoV-2 within 90 minutes using a streamlined RNA extraction method. In total, 509 nasopharyngeal swab (NPS) specimens (SARS-CoV-2 positive: N=205; SARS-CoV-2 negative: N=304) previously tested using the PowerChek SARS-CoV-2 Real-time PCR Kit (Kogene Biotech, Seoul, Korea) were tested using the AdvanSure assay. The limit of detection (LOD) of the AdvanSure assay was determined using serially diluted inactivated SARS-CoV-2. The positive and negative percent agreements between the AdvanSure and PowerChek assays were 99.5% (204/205) and 99.3% (302/304), respectively. The LODs of the AdvanSure assay for SARS-CoV-2 nucleocapsid and spike/RNA-dependent RNA polymerase genes were 672 and 846 copies/mL, respectively. The results show that the performance of the AdvanSure assay is comparable to that of the PowerChek assay used for routine SARS-CoV-2 testing, suggesting that the AdvanSure assay is a useful diagnostic tool for rapid and accurate detection of SARS-CoV-2 infection.
참고문헌 (18)
- Heungsup Sung, "COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays", Annals of Laboratory Medicine, 40(6), pp.439~447 (2020), 대한진단검사의학회[DOI]
- Hong Ki Ho, "Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea", Annals of Laboratory Medicine, 42(4), pp.391~397 (2022), 대한진단검사의학회[DOI]
- Kriegova E, "Direct-RT-qPCR detection of SARS-CoV-2 without RNA extraction as part of a COVID-19 testing strategy: from sample to result in one hour", Diagnostics(Basel), 10, pp.605~ (2020)
- Delgado-Diaz DJ, "Strategies that facilitate extraction-free SARS-CoV-2 nucleic acid amplification tests", Viruses, 14, pp.1311~ (2022)
- Fomsgaard AS, "An alternative workflow for molecular detection of SARS-CoV-2–escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020", Euro Surveill, 25, pp.2000398~ (2020)
- Liotti FM, "Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection", Clin Microbiol Infect, 26, pp.1699~1700 (2020)
- Barza R, "Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection", J Clin Virol, 132, pp.104587~ (2020)
- Hasan MR, "Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA", PLoS One, 15, pp.e0236564~ (2020)
- Mancini F, "Laboratory management for SARS-CoV-2 detection : a user-friendly combination of the heat treatment approach and rt-real-time PCR testing", Emerg Microbes Infect, 9, pp.1393~1396 (2020)
- Merindol N, "SARS-CoV-2 detection by direct rRT-PCR without RNA extraction", J Clin Virol, 128, pp.104423~ (2020)
- Blairon L, "Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time", J Med Virol, 93, pp.2538~2542 (2021)
- Garcia-Venzor A, "SARS-CoV-2 direct detection without RNA isolation with loop-mediated isothermal amplification(LAMP)and CRISPR-Cas12", Front Med(Lausanne), 8, pp.627679~ (2021)
- Genoud V, "Extraction-free protocol combining proteinase K and heat inactivation for detection of SARS-CoV-2 by RT-qPCR", PLoS One, 16, pp.e0247792~ (2021)
- Guan B, "Sensitive extraction-free SARS-CoV-2 RNA virus detection using a chelating resin", iScience, 24, pp.102960~ (2021)
- Mallmann L, "Proteinase K treatment in absence of RNA isolation classical procedures is a quick and cheaper alternative for SARS-CoV-2 molecular detection", J Virol Methods, 293, pp.114131~ (2021)
- Naranbat D, "DirectDetect SARS-CoV-2 direct real-time RT-PCR study using patient samples", ACS Omega, 7, pp.4945~4955 (2022)
- Safiabadi Tali SH, "Tools and techniques for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)", COVID-19 detection, 2021, pp.34, e000228-20~
- Loeffelholz MJ, "Multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test", J Clin Microbiol, 58, pp.e00926-20~ (2020)